ArticleDiabetes, obesity & metabolism2026

Hospitalisation Is a Strong Risk Factor for Discontinuation of Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes.

Tamara Y Milder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.